Related Experiment Video
Updated: Apr 22, 2026
03:53
Author Spotlight: High-Sensitivity Tissue Factor Activity Assay for Plasma Diagnosis
Published on: December 29, 2023
1.4K
Tissue factor and atherothrombosis
1I.P. Pavlov 1st Saint Petersburg State Medical University, Lev Tolstoy Street 6/8, Staint- Petersburg, 197022, Russia. ele195738@yandex.ru.
Current Pharmaceutical Design
|October 15, 2014
Summary
Tissue factor (TF) initiates blood clotting and drives atherosclerosis. Inhibiting TF may prevent cardiovascular events like heart attack and stroke by reducing thrombus formation.
Area of Science:
- Cardiovascular Biology
- Hemostasis and Thrombosis
- Atherosclerosis Pathogenesis
Background:
- Tissue factor (TF) initiates the extrinsic coagulation pathway, crucial for thrombin generation.
- TF is expressed in subendothelial tissues and can be induced on endothelial cells by inflammatory mediators.
- TF plays a critical role in atherosclerotic plaque thrombogenicity and cardiovascular death prediction.
Purpose of the Study:
- To review the role of tissue factor in atherothrombosis.
- To explore TF as a therapeutic target for cardiovascular diseases.
Main Methods:
- Literature review of TF's role in coagulation and atherosclerosis.
- Analysis of TF expression in atherosclerotic plaques.
- Discussion of potential TF-targeted therapies.
Main Results:
- TF is a key determinant of atherosclerotic plaque thrombogenicity.
- Elevated TF levels in plaques correlate with unstable angina.
- Baseline plasma TF activity predicts cardiovascular death in myocardial infarction patients.
Conclusions:
- TF is central to atherothrombosis, particularly after plaque rupture.
- Inhibiting TF activity offers a promising therapeutic strategy for cardiovascular diseases.
- Targeting the TF pathway could reduce the incidence of myocardial infarction, stroke, and sudden death.
More Related Videos
Related Concept Videos
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.6K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
01:16Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
01:30Atherosclerosis I: Introduction
2.2K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.2K
01:26Coronary Artery Disease II: Pathophysiology
1.0K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
01:30Venous Thrombosis I: Introduction
796
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
796